Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory ...

Figure 1: Immunization with recombinant yeast elicits antigen-specific, T-cell protective, cytotoxic and proliferative responses. Figure 2: DCs internalize yeast and efficiently prime MHC class I ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

The Global Albumin Market is expected to grow at a rate of 6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, ...

Martin Vollmer, biopharma program manager at Agilent Technologies, spoke to LCGC International about the evolving importance of glucagon-like peptide-1 (GLP-1) therapeutics and the challenges they ...

Non-Oncology Biopharmaceuticals Market to hit US$ 313.70B by 2033, driven by rising demand for biologics, biosimilars & gene therapies for rare diseases.

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

Shilpa Medicare inks commercial supply deal with Orion for innovative recombinant human albumin: Our Bureau, Bengaluru Friday, June 13, 2025, 14:40 Hrs [IST] Shilpa Biocare, a ful ...